| Page 1841 | Kisaco Research
 

Elisabeth Bik

Scientific Content Directior
uBiome

Elisabeth Bik

Scientific Content Directior
uBiome

Elisabeth Bik

Scientific Content Directior
uBiome
 

Dr. Jordana T. Bell

Senior Lecturer
King's College London

Jordana Bell is a Senior Lecturer at King's College London. She studies the genomic basis of complex human disease in human populations, focusing on intermediate phenotypes including variation in epigenetic and microbiome profiles. In the context of human microbiome research, Jordana has contributed towards characterising host genetic and environmental influences on the gut microbiome, and understanding how  variation in the microbiome relates to metabolic health. 

Dr. Jordana T. Bell

Senior Lecturer
King's College London

Dr. Jordana T. Bell

Senior Lecturer
King's College London

Jordana Bell is a Senior Lecturer at King's College London. She studies the genomic basis of complex human disease in human populations, focusing on intermediate phenotypes including variation in epigenetic and microbiome profiles. In the context of human microbiome research, Jordana has contributed towards characterising host genetic and environmental influences on the gut microbiome, and understanding how  variation in the microbiome relates to metabolic health. 

 

Ronald Tessman

Manager, Clinical Efficacy
Bayer Animal Health

Ronald Tessman

Manager, Clinical Efficacy
Bayer Animal Health

Ronald Tessman

Manager, Clinical Efficacy
Bayer Animal Health
 

Mike Kogut

Research Microbiologist
USDA-ARS

Mike Kogut

Research Microbiologist
USDA-ARS

Mike Kogut

Research Microbiologist
USDA-ARS
 

Rod Mackie

Professor of Microbiology
University of Illinois

Rod Mackie

Professor of Microbiology
University of Illinois

Rod Mackie

Professor of Microbiology
University of Illinois
 

Yemi Adesokan

CEO/CSO and Co-Founder
GNUbiotics

Yemi Adesokan is Chief Scientific Officer and Co-Founder at Gnubiotics SA,  a Lausanne, Switzerland biotech company pioneering the development of Human Milk Oligosacchrides (HMOs) for infants and adults as well as Animal Milk Oligosaccharides (AMOs) for companion animals.  Yemi has been recognized for his innovative and pioneering work with awards such as the Boston Business Journal 40 under 40 award and the  MIT Technology Review’s annual list of 35 top global innovators under the age of 35 TR35.

Yemi Adesokan

CEO/CSO and Co-Founder
GNUbiotics

Yemi Adesokan

CEO/CSO and Co-Founder
GNUbiotics

Yemi Adesokan is Chief Scientific Officer and Co-Founder at Gnubiotics SA,  a Lausanne, Switzerland biotech company pioneering the development of Human Milk Oligosacchrides (HMOs) for infants and adults as well as Animal Milk Oligosaccharides (AMOs) for companion animals.  Yemi has been recognized for his innovative and pioneering work with awards such as the Boston Business Journal 40 under 40 award and the  MIT Technology Review’s annual list of 35 top global innovators under the age of 35 TR35. Yemi has a PhD in Chemistry from the University of California, Irvine and completed a post-doctoral fellowship in Genetics with George Church at Harvard Medical School.

 

 

Jonathon Roepke

Lead Product Development Research Scientist
Microsintesis

Jonathon Roepke

Lead Product Development Research Scientist
Microsintesis

Jonathon Roepke

Lead Product Development Research Scientist
Microsintesis
 

Margie Lee

Head of Department at Biomedical Science and Pathobiology
VA Tech

Margie Lee

Head of Department at Biomedical Science and Pathobiology
VA Tech

Margie Lee

Head of Department at Biomedical Science and Pathobiology
VA Tech
 

Rebecca Blell

Senior Scientist
Borregaard

Talk to me about… your business

As a senior scientist at the R&D center at Borregaard, I focus on the understanding and use of the Exilva products in Personal Care, Home Care and Agrochemical applications. I have now been on this adventure for 4 exciting years.

Rebecca Blell

Senior Scientist
Borregaard

Rebecca Blell

Senior Scientist
Borregaard

Talk to me about… your business

As a senior scientist at the R&D center at Borregaard, I focus on the understanding and use of the Exilva products in Personal Care, Home Care and Agrochemical applications. I have now been on this adventure for 4 exciting years.

Borregaard operates the world's most advanced biorefinery. By using natural, sustainable raw materials, Borregaard produces advanced and environmentally friendly biochemicals and biomaterials that replace oil-based products. The Borregaard Group has 1080 employees in 16 countries.

Talk to me about…something people may not know about you

Born and raised in Sierra Leone, West Africa. After high school, I decided to become a researcher so I had to move out of that tropical paradise. I travelled quite much and lived in 6 different countries for more than 1 year before the age of 30. I speak 4 languages and understand a few more so I find myself in very awkward situations involuntarily understanding a “secret conversation” on a bus or a train which the person speaking wouldn’t have expected me to understand. It’s a nice ice breaker in many situations. I now live and work in Norway.